new oral glp 1 Head-to-head trial shows Eli Lilly's GLP-1 orforglipron outperforms oral semaglutide Lilly's Oral GLP-1 Foundayo Outperforms

Indian patients with the thin-fat phenotype often experience disproportionately high improvements in waist circumference and metabolic markers even with modest overall weight loss, because GLP-1 preferentially targets the visceral fat that drives metabolic disease

A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the Gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy

In most cases, it reflects temporary changes in hydration, nutrition, or circulation rather than a serious concern

By slowing digestion and influencing appetite signals in the brain, these drugs help people feel full longer and reduce food intake

Eat Fewer Ultra-Processed Convenience Foods Packaged snacks and heavily processed meals, such as chips, crackers, instant noodles, and frozen microwave meals, often combine refined carbs, added fats, and sodium in ways that could raise your blood sugar

Treatment options in 2025